HALO Halozyme Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026HALO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
HALO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Halozyme Therapeutics, Inc. - Common Stock Company overview from Wikipedia
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | HALO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 32.15Y avg ≈22.4 | ≈22.4 | 24.7 | Undervalued | |
| P/S (TTM) | 7.55Y avg ≈8.2 | ≈8.2 | 9.7 | Undervalued | |
| P/B (MRQ) | 87.35Y avg ≈61.6 | ≈61.6 | 11.3 | Overvalued | |
| EV / EBITDA | 31.15Y avg ≈21.3 | ≈21.3 | · | · | |
| Price / FCF (TTM) | 15.55Y avg ≈17.7 | ≈17.7 | · | · | |
| Price / Cash Flow (TTM) | 15.35Y avg ≈17.4 | ≈17.4 | 13.8 | Undervalued | |
| EV / Revenue | 10.75Y avg ≈9.9 | ≈9.9 | · | · | |
| EV / FCF | 23.25Y avg ≈21.3 | ≈21.3 | · | · | |
| Price / Tangible Book (MRQ) | -16.1 | · | · | · | |
| PEG Ratio | ≈1.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | HALO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 35.9%5Y avg ≈46.3% | ≈46.3% | 11.2% | Top tier | |
| EBITDA Margin (TTM) | 36.8%5Y avg ≈47.2% | ≈47.2% | 11.2% | Top tier | |
| Pretax Margin (TTM) | 35.1%5Y avg ≈44.8% | ≈44.8% | 6.2% | Top tier | |
| Net Profit Margin (TTM) | 24.9%5Y avg ≈44.4% | ≈44.4% | 4.5% | Top tier | |
| ROA (TTM) | 17.9%5Y avg ≈22.9% | ≈22.9% | -3.8% | Top tier | |
| ROE (TTM) | 173.7%5Y avg ≈152.8% | ≈152.8% | 17.1% | Top tier | |
| ROIC | 14.5%5Y avg ≈22.0% | ≈22.0% | 14.3% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | HALO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 15.05Y avg ≈15.8 | ≈15.8 | 0.4 | High debt | |
| Current Ratio (MRQ) | 2.75Y avg ≈6.5 | ≈6.5 | 3.0 | In line | |
| Quick Ratio | 3.25Y avg ≈2.5 | ≈2.5 | 1.9 | In line | |
| Long-Term Debt / Equity (MRQ) | 13.55Y avg ≈15.7 | ≈15.7 | 0.6 | High debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | HALO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 37.5%5Y avg ≈40.0% | ≈40.0% | · | · | |
| Revenue CAGR 3Y | 28.4%5Y avg ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y | 39.2% | · | · | · | |
| EPS YoY | -25.4%5Y avg ≈47.5% | ≈47.5% | · | · | |
| Net Income YoY | -28.6%5Y avg ≈46.1% | ≈46.1% | · | · | |
| EPS CAGR 3Y | 21.1%5Y avg ≈20.4% | ≈20.4% | · | · | |
| EPS CAGR 5Y | 23.0% | · | · | · | |
| Net Income CAGR 3Y | 16.2%5Y avg ≈16.4% | ≈16.4% | · | · | |
| Net Income CAGR 5Y | 19.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | HALO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.5 | ≈0.5 | 0.6 | In line | |
| Inventory Turnover | 1.45Y avg ≈1.5 | ≈1.5 | 1.1 | Top tier | |
| Receivables Turnover | 3.95Y avg ≈4.2 | ≈4.2 | 5.0 | Weak | |
| Revenue / Employee | ≈$3.3M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $2.28 | $1.87 | 21.7% |
| March 31, 2026 | May 12, 2026 | $1.60 | $1.56 | 2.5% |
| Dec. 31, 2025 | $-0.24 | $2.24 | -110.7% | |
| Sept. 30, 2025 | $1.72 | $1.66 | 3.6% | |
| June 30, 2025 | $1.54 | $1.29 | 19.3% | |
| March 31, 2025 | $1.11 | $0.97 | 14.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.02B | $829M | $660M | $443M | $268M | $196M | $152M | $317M | $147M | $135M | $75M | |
| Cost of Revenue | $229M | $159M | $192M | $139M | $81M | $43M | $46M | $10M | $31M | $33M | $29M | $23M | |
| R&D Expense | · | $79M | $76M | $67M | $36M | $34M | $141M | $150M | $151M | $151M | $93M | $80M | |
| SG&A Expense | $207M | $154M | $149M | $144M | $50M | $46M | $77M | $61M | $54M | $46M | $40M | $36M | |
| Operating Expenses | $928M | $464M | $492M | $393M | $167M | $123M | $264M | · | · | $230M | $163M | $138M | |
| Operating Income | $469M | $551M | $338M | $268M | $276M | $144M | $-68M | $-69M | $81M | $-83M | $-27M | $-63M | |
| Interest Expense | · | · | $19M | $17M | $8M | $20M | $12M | $18M | $22M | $20M | $5M | $6M | |
| Other Non-op | $21M | $24M | $16M | $1M | $1M | $5M | $7M | $8M | $3M | $1M | $422.0K | · | |
| Pretax Income | $467M | $557M | $348M | $249M | $249M | $129M | $-72M | $-80M | $62M | $-102M | $-32M | $-68M | |
| Income Tax | $150M | $113M | $67M | $47M | $-154M | $217.0K | $-11.0K | $537.0K | $-1M | $1M | $0 | $0 | |
| Net Income | $317M | $444M | $282M | $202M | $403M | $129M | $-72M | $-80M | $63M | $-103M | $-32M | $-68M | |
| EPS (Basic) | $2.64 | $3.50 | $2.13 | $1.48 | $2.86 | $0.95 | $-0.50 | $-0.56 | $0.46 | $-0.81 | $-0.25 | · | |
| EPS (Diluted) | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 | $0.91 | $-0.50 | $-0.56 | $0.45 | $-0.81 | $-0.25 | · | |
| Shares (Basic) | 119,840,000 | 126,827,000 | 131,927,000 | 136,844,000 | 140,646,000 | 136,206,000 | 144,329,000 | 143,599,000 | 136,419,000 | 127,964,000 | 126,704,000 | · | |
| Shares (Diluted) | 123,904,000 | 129,424,000 | 134,197,000 | 140,608,000 | 146,796,000 | 141,463,000 | 144,329,000 | 143,599,000 | 139,068,000 | 127,964,000 | 126,704,000 | · | |
| EBITDA | $480M | $562M | $349M | $274M | $279M | $148M | $-64M | $-67M | $83M | $-81M | $-26M | $-61M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $134M | $116M | $118M | $234M | $119M | $148M | $120M | $58M | $169M | $67M | $43M | $61M | |
| Short-term Investments | · | · | · | · | · | · | $301M | $297M | $300M | $138M | $65M | $74M | |
| Receivables | $426M | $288M | $233M | $187M | $91M | $98M | $59M | $30M | $22M | $16M | $32M | $9M | |
| Inventory | $176M | $142M | $128M | $100M | $54M | $61M | $29M | $23M | $5M | $15M | $9M | $6M | |
| Prepaid Expense | $65M | $39M | $49M | $45M | $40M | $28M | $33M | $21M | $14M | $21M | $22M | $10M | |
| Current Assets | $825M | $1.09B | $746M | $739M | $926M | $555M | $543M | $428M | $510M | $257M | $172M | $161M | |
| PP&E (Net) | $44M | $41M | $38M | $35M | $7M | $7M | $11M | $7M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | $78M | $66M | $58M | $50M | $20M | $19M | $18M | $24M | $17M | $16M | $14M | $12M | |
| Accum. Depreciation | $33M | $25M | $20M | $15M | $13M | $12M | · | $16M | $14M | $12M | $10M | $9M | |
| Goodwill | $580M | $417M | $417M | $409M | $0 | · | · | · | · | · | · | · | |
| Intangibles | $981M | $402M | $473M | $547M | $0 | · | · | · | · | · | · | · | |
| Total Assets | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $580M | $566M | $440M | $520M | $262M | $182M | $166M | |
| Accounts Payable | $21M | $10M | $12M | $18M | $2M | $2M | $6M | $4M | $8M | $4M | $4M | $3M | |
| Accrued Liabilities | $156M | $129M | $101M | $100M | $24M | $20M | $56M | $50M | $40M | $29M | $27M | $14M | |
| Current Liabilities | $177M | $139M | $112M | $131M | $117M | $421M | $86M | $149M | $131M | $55M | $62M | $24M | |
| Deferred Tax | $43M | $0 | $0 | · | $0 | · | $16M | $858.0K | $173.0K | $340.0K | $380.0K | $194.0K | |
| Other Non-current Liabilities | $114M | $55M | $38M | $33M | $544.0K | $3M | $4M | $2M | $814.0K | $358.0K | $4M | $3M | |
| Total Liabilities | $2.48B | $1.70B | $1.65B | $1.67B | · | · | · | · | · | · | · | · | |
| Long-term Debt | $2.14B | $1.51B | $1.50B | $1.51B | $787M | $0 | $383M | $35M | $125M | $199M | $28M | $50M | |
| Total Debt | $2.14B | $1.51B | $1.50B | $1.51B | $877M | $397M | $403M | $126M | $202M | $217M | $50M | $50M | |
| Common Stock | $118.0K | $123.0K | $127.0K | $135.0K | $138.0K | $135.0K | $137.0K | $145.0K | $143.0K | $130.0K | $128.0K | $126.0K | |
| Retained Earnings | $55M | $360M | $91M | $143M | $-59M | $-475M | $-604M | $-531M | $-522M | $-585M | $-483M | $-450M | |
| AOCI | $-18M | $4M | $-9M | $-922.0K | $-620.0K | $22.0K | $240.0K | $-277.0K | $-450.0K | $-6.0K | $-99.0K | $-41.0K | |
| Stockholders' Equity | $49M | $364M | $84M | $170M | $197M | $151M | $92M | $249M | $208M | $-32M | $43M | $41M | |
| Liabilities + Equity | $2.53B | $2.06B | $1.73B | $1.84B | $1.10B | $580M | $566M | $440M | $520M | $262M | $182M | $166M | |
| Shares Outstanding | 117,782,000 | 123,138,000 | 126,770,000 | 135,154,000 | 137,498,000 | 135,030,000 | 136,712,580 | 144,725,164 | 142,789,000 | 129,502,000 | 128,152,000 | 125,721,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $10M | $11M | $6M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $52M | $43M | $37M | $24M | $21M | $17M | $35M | $36M | $31M | $26M | $21M | $15M | |
| Amort. of Intangibles | $77M | $71M | $74M | $43M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $272M | $-19M | $59M | $7M | $-127M | $-94M | $-52M | $-7M | $38M | $25M | $-27M | $4M | |
| Operating Cash Flow | $652M | $479M | $389M | $240M | $299M | $55M | $-85M | $-50M | $134M | $-50M | $-37M | $-48M | |
| CapEx | $7M | $11M | $15M | $5M | $1M | $3M | $4M | $5M | $1M | $3M | $2M | $1M | |
| Investing Cash Flow | $-546M | $-263M | $-97M | $-487M | $-406M | $78M | $-6M | $2M | $-164M | $-77M | $6M | $-33M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $135M | $0 | $0 | $108M | |
| Stock Repurchased | $342M | $250M | $402M | $200M | $350M | $150M | $200M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-342M | $-250M | $-402M | $-200M | $-350M | $-150M | $-200M | $0 | $135M | $0 | $0 | $108M | |
| Financing Cash Flow | $-85M | $-219M | $-408M | $362M | $78M | $-106M | $153M | $-64M | $132M | $151M | $13M | $115M | |
| Net Change in Cash | $21M | $-3M | $-116M | $115M | $-29M | $28M | $62M | $-111M | $102M | $23M | $-18M | $34M | |
| Taxes Paid | $135M | $81M | $32M | $16M | $-375.0K | $180.0K | · | · | · | · | · | · | |
| Free Cash Flow | $645M | $468M | $373M | $235M | $298M | $53M | $-89M | $-54M | $133M | $-54M | $-39M | $-49M | |
| Levered FCF | · | · | $358M | $222M | $286M | $33M | $-101M | $-72M | $110M | $-74M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% | · | · | -45.6% | 25.6% | -56.7% | -20.3% | -83.7% | |
| Net Margin | 22.7% | 43.7% | 34.0% | 30.6% | 90.8% | · | · | -52.9% | 19.9% | -70.2% | -23.9% | -90.8% | |
| Pretax Margin | 33.4% | 54.9% | 42.0% | 37.7% | 56.1% | · | · | -52.5% | 19.5% | -69.4% | · | · | |
| EBITDA Margin | 34.4% | 55.3% | 42.0% | 41.5% | 62.9% | · | · | -44.1% | 26.3% | -55.1% | -19.1% | -81.3% | |
| ROA | 13.8% | 23.4% | 15.8% | 13.7% | 47.8% | 22.5% | -14.4% | -16.7% | 16.1% | -46.5% | -18.5% | -51.1% | |
| ROE | 166.1% | 108.8% | 169.1% | 151.5% | 168.3% | 103.2% | -42.9% | -32.9% | 71.6% | -1959.0% | -76.4% | -640.2% | |
| ROIC | 14.5% | 23.5% | 17.2% | 13.0% | 41.6% | 26.3% | -13.7% | -18.6% | 20.2% | -45.7% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 7.8 | 6.6 | 5.7 | 7.9 | 1.3 | 6.3 | 2.9 | 3.9 | 4.7 | 2.8 | 6.6 | |
| Quick Ratio | 3.2 | 2.9 | 1.1 | 3.6 | 1.8 | 0.6 | 5.6 | 2.6 | 3.7 | 4.0 | 2.3 | 6.0 | |
| Debt / Equity | 43.9 | 4.1 | 17.9 | 8.9 | 4.5 | 2.6 | 4.4 | 0.5 | 1.0 | -6.7 | 1.2 | 1.2 | |
| LT Debt / Equity | 43.9 | 4.1 | 17.9 | 8.8 | 4.0 | 0.0 | 4.2 | 0.1 | 0.6 | -6.1 | 0.7 | 1.2 | |
| Interest Coverage | · | · | 18.0 | 15.8 | 36.7 | 7.1 | -5.8 | -3.8 | 3.7 | -4.2 | -5.3 | -11.3 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | · | · | 0.3 | 0.8 | 0.7 | 0.8 | 0.6 | |
| Inventory Turnover | 1.4 | 1.2 | 1.7 | 1.8 | 1.4 | 1.0 | 1.8 | 0.7 | 3.2 | 2.8 | 3.7 | 3.6 | |
| Receivables Turnover | 3.9 | 3.9 | · | 4.1 | 4.7 | · | · | 5.8 | 16.7 | 6.1 | 6.5 | 8.3 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.41 | $2.95 | $0.66 | $1.26 | $1.43 | $1.12 | $0.67 | $1.74 | $1.46 | $-0.25 | $0.34 | $0.33 | |
| Revenue / Share | $11.27 | $7.84 | $6.18 | $4.69 | $3.02 | · | · | $1.06 | $2.28 | · | · | · | |
| Cash Flow / Share | $5.26 | $3.70 | $2.90 | $1.71 | $2.04 | $0.39 | $-0.59 | $-0.34 | $0.96 | · | · | · | |
| Cash / Share | $1.14 | $0.94 | $0.93 | $1.73 | $0.86 | $1.09 | $0.88 | $0.41 | $1.18 | $0.52 | $0.34 | $0.49 | |
| EPS (TTM) | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 | $0.91 | $-0.50 | $-0.56 | $0.45 | $-0.81 | $-0.25 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 37.5% | 22.4% | 25.6% | 48.9% | 65.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 28.4% | 31.8% | 45.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.4% | 63.3% | 45.8% | -47.4% | 201.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 21.1% | 7.8% | 32.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 23.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -28.6% | 57.7% | 39.3% | -49.8% | 212.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 16.2% | 3.3% | 29.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 19.7% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.02B | $829M | $660M | $443M | $268M | $196M | $152M | $317M | $147M | $135M | $75M | |
| Net Income TTM | $317M | $444M | $282M | $202M | $403M | $129M | $-72M | $-80M | $63M | $-103M | $-32M | $-68M | |
| Market Cap | $7.93B | $5.89B | $4.69B | $7.69B | $5.53B | $5.77B | $2.42B | $2.09B | $2.89B | $1.28B | $2.22B | $1.21B | |
| Enterprise Value | $9.94B | $7.28B | $6.07B | $8.96B | $6.29B | $6.02B | $2.41B | $1.86B | $2.63B | $1.29B | $2.16B | $1.13B | |
| P/E | 26.3 | 13.9 | 17.6 | 39.5 | 14.7 | 46.9 | -35.5 | -26.1 | 45.0 | -12.2 | -69.3 | · | |
| P/S | 5.7 | 5.8 | 5.7 | 11.6 | 12.5 | 21.6 | 12.4 | 13.8 | 9.1 | 8.7 | 16.4 | 16.1 | |
| P/B | 162.4 | 16.2 | 55.9 | 45.3 | 28.1 | 38.2 | 26.4 | 8.4 | 13.9 | -39.4 | 51.6 | 29.3 | |
| P / Tangible Book | · | · | · | · | 28.1 | 38.2 | · | · | · | · | · | · | |
| P / Cash Flow | 12.2 | 12.3 | 12.1 | 32.0 | 18.5 | 104.0 | -28.4 | -42.2 | 21.6 | -25.4 | -59.9 | -25.5 | |
| P / FCF | 12.3 | 12.6 | 12.6 | 32.7 | 18.6 | 108.9 | -27.1 | -38.6 | 21.8 | -23.9 | -56.3 | -24.8 | |
| EV / EBITDA | 20.7 | 13.0 | 17.4 | 32.7 | 22.5 | 40.8 | -37.9 | -27.8 | 31.6 | -16.0 | -83.9 | -18.4 | |
| EV / FCF | 15.4 | 15.5 | 16.3 | 38.1 | 21.1 | 113.6 | -26.9 | -34.4 | 19.8 | -24.1 | -54.8 | -23.1 | |
| EV / Revenue | 7.1 | 7.2 | 7.3 | 13.6 | 14.2 | 22.5 | 12.3 | 12.3 | 8.3 | 8.8 | 16.0 | 15.0 | |
| Earnings Yield | 3.8% | 7.2% | 5.7% | 2.5% | 6.8% | 2.1% | -2.8% | -3.8% | 2.2% | -8.2% | -1.4% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $481M | $377M | $452M | $354M | $326M | $265M | $298M | $290M | $231M | $196M | $230M | $216M | $221M | $162M | $181M | $209M | |
| Cost of Revenue | $79M | $79M | $79M | $55M | $46M | $48M | $42M | $49M | $40M | $28M | $52M | $55M | $50M | $35M | $42M | $47M | |
| R&D Expense | $28M | $26M | · | $17M | $18M | $15M | · | $18M | $21M | $19M | · | $17M | $20M | $18M | $23M | $17M | |
| SG&A Expense | $57M | $58M | $77M | $46M | $42M | $42M | $42M | $41M | $36M | $35M | $38M | $35M | $39M | $37M | $38M | $34M | |
| Operating Expenses | $193M | $192M | $545M | $136M | $123M | $123M | $123M | $127M | $114M | $100M | $129M | $128M | $127M | $108M | $107M | $126M | |
| Operating Income | $288M | $185M | $-93M | $218M | $202M | $142M | $176M | $163M | $117M | $96M | $101M | $88M | $94M | $54M | $75M | $83M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $4M | $5M | · | $8M | |
| Other Non-op | $3M | $1M | $2M | $5M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $852.0K | $641.0K | |
| Pretax Income | $285M | $180M | $-101M | $219M | $205M | $144M | $178M | $165M | $118M | $96M | $101M | $102M | $93M | $52M | $71M | $74M | |
| Income Tax | $55M | $30M | $41M | $44M | $40M | $26M | $41M | $28M | $24M | $19M | $16M | $20M | $18M | $13M | $13M | $12M | |
| Net Income | $230M | $150M | $-142M | $175M | $165M | $118M | $137M | $137M | $93M | $77M | $85M | $82M | $75M | $40M | $58M | $62M | |
| EPS (Basic) | $1.96 | $1.27 | $-1.17 | $1.49 | $1.36 | $0.96 | $1.08 | $1.08 | $0.73 | $0.61 | $0.65 | $0.62 | $0.57 | $0.29 | $0.43 | $0.45 | |
| EPS (Diluted) | $1.90 | $1.22 | $-1.13 | $1.43 | $1.33 | $0.93 | $1.06 | $1.05 | $0.72 | $0.60 | $0.64 | $0.61 | $0.56 | $0.29 | $0.41 | $0.44 | |
| Shares (Basic) | 117,274,000 | 118,144,000 | · | 117,219,000 | 121,343,000 | 123,215,000 | · | 126,850,000 | 127,116,000 | 126,941,000 | · | 131,965,000 | 131,730,000 | 135,027,000 | · | 136,527,000 | |
| Shares (Diluted) | 121,215,000 | 122,875,000 | · | 122,331,000 | 124,158,000 | 126,644,000 | · | 130,134,000 | 129,222,000 | 128,887,000 | · | 134,083,000 | 133,543,000 | 137,900,000 | · | 139,387,000 | |
| EBITDA | $292M | $189M | · | $221M | $205M | $144M | · | $166M | $120M | $98M | · | $91M | $97M | $56M | · | $85M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $310M | $134M | $420M | $62M | $176M | $116M | $154M | $188M | $165M | $118M | $274M | $221M | $96M | · | $147M | |
| Receivables | $453M | $458M | $426M | $344M | $315M | $304M | $288M | $273M | $210M | $185M | · | $214M | $222M | $195M | · | $233M | |
| Inventory | $137M | $155M | $176M | $186M | $182M | $165M | $142M | $131M | $159M | $169M | · | $129M | $132M | $108M | · | $103M | |
| Prepaid Expense | $109M | $71M | $65M | $95M | $77M | $45M | $39M | $44M | $85M | $46M | · | $49M | $39M | $37M | · | $51M | |
| Current Assets | $933M | $1.00B | $825M | $1.33B | $1.12B | $1.26B | $1.09B | $1.13B | $988M | $874M | · | $879M | $766M | $615M | · | $653M | |
| PP&E (Net) | $50M | $47M | $44M | $41M | $40M | $40M | $41M | $40M | $40M | $42M | · | $37M | $36M | $39M | · | $31M | |
| PP&E (Gross) | $84M | $82M | $78M | $72M | $69M | $67M | $66M | $64M | $62M | $63M | · | $56M | $53M | $55M | · | $46M | |
| Accum. Depreciation | $34M | $35M | $33M | $31M | $29M | $27M | $25M | $24M | $22M | $21M | · | $18M | $17M | $16M | · | $15M | |
| Goodwill | $582M | $582M | $580M | $417M | $417M | $417M | $417M | $417M | $417M | $417M | · | $417M | $417M | $416M | · | $199M | |
| Intangibles | $922M | $952M | $981M | $349M | $366M | $384M | $402M | $420M | $437M | $455M | · | $491M | $511M | $529M | · | $949M | |
| Total Assets | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | · | $1.89B | $1.81B | $1.70B | · | $1.86B | |
| Accounts Payable | $24M | $14M | $21M | $15M | $19M | $20M | $10M | $12M | $15M | $13M | · | $19M | $10M | $9M | · | $18M | |
| Accrued Liabilities | $112M | $140M | $156M | $111M | $116M | $130M | $129M | $96M | $118M | $118M | · | $95M | $105M | $80M | · | $74M | |
| Current Liabilities | $344M | $363M | $177M | $837M | $134M | $150M | $139M | $109M | $133M | $132M | · | $115M | $116M | $92M | · | $109M | |
| Deferred Tax | $49M | $48M | $43M | $8M | · | · | $0 | $12M | $14M | · | · | · | · | · | · | $29M | |
| Other Non-current Liabilities | $103M | $106M | $114M | $72M | $78M | $56M | $55M | $40M | $31M | $31M | · | $28M | $31M | $30M | · | $5M | |
| Total Liabilities | $2.43B | $2.45B | $2.48B | $1.72B | $1.72B | $1.71B | $1.70B | $1.67B | $1.68B | $1.66B | · | $1.64B | $1.66B | $1.63B | · | · | |
| Long-term Debt | $2.15B | $2.14B | $2.14B | $1.51B | $1.51B | $1.51B | $1.51B | $1.50B | $1.50B | $1.50B | · | $1.50B | $1.50B | $1.49B | · | $1.50B | |
| Total Debt | $2.15B | $2.14B | · | $1.51B | $1.51B | $1.51B | · | $1.50B | $1.50B | $1.50B | · | $1.50B | $1.50B | $1.49B | · | $1.50B | |
| Common Stock | $114.0K | $118.0K | $118.0K | $118.0K | $118.0K | $123.0K | $123.0K | $127.0K | $127.0K | $127.0K | · | $132.0K | $132.0K | $132.0K | · | $135.0K | |
| Retained Earnings | $151M | $205M | $55M | $502M | $361M | $478M | $360M | $398M | $261M | $167M | · | $222M | $140M | $66M | · | $86M | |
| AOCI | $-8M | $-13M | $-18M | $-22M | $-28M | $-3M | $4M | $-7M | $-2M | $-1M | · | $1M | $-2M | $24.0K | · | $-2M | |
| Stockholders' Equity | $144M | $220M | $49M | $504M | $333M | $482M | $364M | $453M | $289M | $178M | $84M | $249M | $151M | $66M | $170M | $97M | |
| Liabilities + Equity | $2.58B | $2.67B | $2.53B | $2.22B | $2.05B | $2.20B | $2.06B | $2.12B | $1.97B | $1.84B | · | $1.89B | $1.81B | $1.70B | · | $1.86B | |
| Shares Outstanding | 114,042,000 | 118,523,000 | 117,782,000 | 117,523,000 | 117,621,000 | 123,170,000 | 123,138,000 | 127,183,000 | 126,535,000 | 127,186,000 | · | 132,081,000 | 131,856,000 | 131,662,000 | · | 135,211,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $18M | $17M | $17M | $12M | $12M | $11M | $11M | $13M | $9M | $10M | $10M | $9M | $10M | $8M | $7M | $7M | |
| Amort. of Intangibles | $30M | $30M | $23M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $20M | $18M | $18M | $5M | $27M | |
| Other Non-cash | · | $9M | · | · | · | $23M | · | · | · | $40M | · | · | · | $37M | · | · | |
| Operating Cash Flow | $241M | $180M | $219M | $179M | $100M | $154M | $178M | $115M | $56M | $129M | $102M | $132M | $67M | $87M | $82M | $70M | |
| CapEx | $4M | $4M | $1M | $3M | $2M | $950.0K | $3M | $2M | $3M | $4M | $3M | $3M | $-2M | $11M | $2M | $1M | |
| Investing Cash Flow | $-63M | $-3M | $-742M | $202M | $85M | $-90M | $29M | $-167M | $-42M | $-83M | $-8M | $-83M | $55M | $-60M | $-2M | $-1M | |
| Stock Repurchased | · | · | $0 | $39M | · | · | $250M | $0 | $0 | $0 | $252M | $0 | $0 | $150M | $1.0K | $200M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-150M | · | · | |
| Financing Cash Flow | $-326M | $-2M | $240M | $-22M | $-299M | $-3M | $-246M | $19M | $9M | $-489.0K | $-250M | $4M | $2M | $-165M | $6M | $-12M | |
| Net Change in Cash | $-148M | $176M | $-283M | $358M | $-114M | $60M | $-38M | $-34M | $23M | $46M | $-156M | $53M | $124M | $-138M | $87M | $56M | |
| Free Cash Flow | · | $176M | · | · | · | $153M | · | · | · | $126M | · | · | · | $76M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $122M | · | · | · | $72M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 59.8% | 49.0% | · | 61.5% | 62.2% | 53.4% | · | 56.3% | 50.7% | 48.8% | · | 40.9% | 42.7% | 33.2% | · | 39.9% | |
| Net Margin | 47.8% | 39.8% | · | 49.5% | 50.7% | 44.6% | · | 47.2% | 40.3% | 39.2% | · | 37.9% | 33.8% | 24.4% | · | 29.5% | |
| Pretax Margin | 59.2% | 47.9% | · | 61.8% | 62.9% | 54.3% | · | 56.9% | 50.9% | 49.0% | · | 47.1% | 42.1% | 32.2% | · | 35.3% | |
| EBITDA Margin | 60.7% | 50.1% | · | 62.3% | 63.0% | 54.4% | · | 57.1% | 51.8% | 50.0% | · | 42.1% | 44.0% | 34.8% | · | 40.8% | |
| ROA | 9.9% | 6.2% | · | 8.1% | 8.2% | 5.9% | · | 6.8% | 4.9% | 4.3% | · | 4.4% | 4.2% | 2.8% | · | 4.0% | |
| ROE | 96.5% | 42.8% | · | 36.6% | 53.1% | 35.8% | · | 39.0% | 42.3% | 63.1% | · | 47.3% | 33.7% | 24.3% | · | 32.6% | |
| ROIC | 10.1% | 6.5% | · | 8.7% | 8.9% | 5.8% | · | 6.9% | 5.2% | 4.5% | · | 4.1% | 4.6% | 2.6% | · | 4.3% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.8 | · | 1.6 | 8.4 | 8.4 | · | 10.4 | 7.4 | 6.6 | · | 7.6 | 6.6 | 6.7 | · | 6.0 | |
| Quick Ratio | 1.8 | 2.1 | · | 0.9 | 2.8 | 3.2 | · | 3.9 | 3.0 | 2.7 | · | 4.2 | 3.8 | 3.2 | · | 3.5 | |
| Debt / Equity | 15.0 | 9.8 | · | 3.0 | 4.5 | 3.1 | · | 3.3 | 5.2 | 8.4 | · | 6.0 | 9.9 | 22.7 | · | 15.5 | |
| LT Debt / Equity | 13.5 | 8.8 | · | 1.6 | 4.5 | 3.1 | · | 3.3 | 5.2 | 8.4 | · | 6.0 | 9.9 | 22.7 | · | 15.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 21.2 | · | 19.6 | 21.0 | 11.8 | · | 11.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.2 | · | 0.5 | 0.4 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.3 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.26 | $1.85 | · | $4.29 | $2.83 | $3.92 | · | $3.56 | $2.29 | $1.40 | · | $1.89 | $1.15 | $0.50 | · | $0.72 | |
| Revenue / Share | $3.97 | $3.07 | · | $2.90 | $2.62 | $2.09 | · | $2.23 | $1.79 | $1.52 | · | $1.61 | $1.66 | $1.18 | · | $1.50 | |
| Cash Flow / Share | · | $1.47 | · | · | · | $1.22 | · | · | · | $1.00 | · | · | · | $0.63 | · | · | |
| Cash / Share | $1.43 | $2.61 | · | $3.57 | $0.53 | $1.43 | · | $1.21 | $1.48 | $1.29 | · | $2.08 | $1.68 | $0.73 | · | $1.09 | |
| EPS (TTM) | $3.42 | $2.85 | · | $4.75 | $4.37 | $3.76 | · | $3.01 | $2.57 | $2.41 | · | $1.87 | $1.70 | $1.30 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.66B | $1.51B | · | $1.24B | $1.18B | $1.08B | · | $947M | $873M | $863M | · | $781M | $774M | $705M | · | · | |
| Net Income TTM | $414M | $349M | · | $595M | $557M | $485M | · | $392M | $337M | $319M | · | $254M | $234M | $182M | · | · | |
| Market Cap | $8.93B | $7.66B | · | $8.62B | $6.12B | $7.86B | · | $7.28B | $6.63B | $5.17B | · | $5.05B | $4.76B | $5.03B | · | $5.35B | |
| Enterprise Value | $10.91B | $9.50B | · | $9.71B | $7.57B | $9.19B | · | $8.63B | $7.94B | $6.51B | · | $6.27B | $6.03B | $6.43B | · | $6.70B | |
| P/E | 22.9 | 22.7 | · | 15.4 | 11.9 | 17.0 | · | 19.0 | 20.4 | 16.9 | · | 20.4 | 21.2 | 29.4 | · | · | |
| P/S | 5.4 | 5.1 | · | 6.9 | 5.2 | 7.2 | · | 7.7 | 7.6 | 6.0 | · | 6.5 | 6.1 | 7.1 | · | · | |
| P/B | 62.2 | 34.9 | · | 17.1 | 18.4 | 16.3 | · | 16.1 | 22.9 | 29.1 | · | 20.2 | 31.5 | 76.4 | · | 55.1 | |
| P / Cash Flow | · | 42.5 | · | · | · | 51.0 | · | · | · | 40.0 | · | · | · | 57.8 | · | · | |
| EV / Revenue | 6.6 | 6.3 | · | 7.8 | 6.4 | 8.5 | · | 9.1 | 9.1 | 7.5 | · | 8.0 | 7.8 | 9.1 | · | · | |
| Earnings Yield | 4.4% | 4.4% | · | 6.5% | 8.4% | 5.9% | · | 5.3% | 4.9% | 5.9% | · | 4.9% | 4.7% | 3.4% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $1.40B | $1.02B | $829M | $660M | $443M |
| Operating Margin % | 33.6% | 54.3% | 40.7% | 40.5% | 62.2% |
| Net Income | $317M | $444M | $282M | $202M | $403M |
| Diluted EPS | $2.56 | $3.43 | $2.10 | $1.44 | $2.74 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 43.9 | 4.1 | 17.9 | 8.9 | 4.5 |
| Current Ratio | 4.7 | 7.8 | 6.6 | 5.7 | 7.9 |
| Quick Ratio | 3.2 | 2.9 | 1.1 | 3.6 | 1.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $645M | $468M | $373M | $235M | $298M |
Institutional owners (13F) 718 filers · $10.0B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 98 (-21 vs prior Q) | 64 (0 vs prior Q) | 272 (+43 vs prior Q) | 206 (-3 vs prior Q) | +4.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $1,038,728,610 | 13,271,095 | 10.37% | Shares |
| VANGUARD GROUP INC | $778,452,101 | 11,566,896 | 7.77% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $418,847,190 | 5,351,312 | 4.18% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $414,753,356 | 5,299,008 | 4.14% | Shares |
| STATE STREET CORP | $405,379,779 | 5,179,434 | 4.05% | Shares |
| Invesco Ltd. | $248,741,825 | 3,177,997 | 2.48% | Shares |
| MORGAN STANLEY | $221,707,309 | 2,832,594 | 2.21% | Shares |
| Boston Partners | $216,820,544 | 2,773,568 | 2.16% | Shares |
| BANK OF AMERICA CORP /DE/ | $214,503,722 | 2,740,561 | 2.14% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $197,281,725 | 2,519,951 | 1.97% | Shares |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $196,539,884 | 2,511,050 | 1.96% | Shares |
| SNYDER CAPITAL MANAGEMENT L P | $187,542,825 | 2,396,101 | 1.87% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $163,542,164 | 2,089,567 | 1.63% | Shares |
| D. E. Shaw & Co., Inc. | $157,047,112 | 2,006,479 | 1.57% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $151,690,000 | 1,938,035 | 1.51% | Shares |
| ROYAL LONDON ASSET MANAGEMENT LTD | $141,732,491 | 1,810,815 | 1.42% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $133,420,842 | 1,704,623 | 1.33% | Shares |
| TWO SIGMA INVESTMENTS, LP | $129,402,617 | 1,653,285 | 1.29% | Shares |
| UBS Group AG | $116,796,372 | 1,492,224 | 1.17% | Shares |
| FULLER & THALER ASSET MANAGEMENT, INC. | $116,700,910 | 1,491,004 | 1.17% | Shares |
| NORGES BANK | $116,125,129 | 1,483,648 | 1.16% | Shares |
| FIRST TRUST ADVISORS LP | $110,913,469 | 1,417,063 | 1.11% | Shares |
| ALLIANCEBERNSTEIN L.P. | $109,647,251 | 1,696,538 | 1.09% | Shares |
| Stephens Investment Management Group LLC | $109,015,943 | 1,392,819 | 1.09% | Shares |
| WELLS FARGO & COMPANY/MN | $108,828,836 | 1,390,428 | 1.09% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $103,520,920 | 1,322,613 | 1.03% | Shares |
| GOLDMAN SACHS GROUP INC | $99,429,825 | 1,270,344 | 0.99% | Shares |
| FRANKLIN RESOURCES INC | $97,371,010 | 1,244,040 | 0.97% | Shares |
| CONGRESS ASSET MANAGEMENT CO | $96,202,127 | 1,229,106 | 0.96% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $92,656,000 | 1,183,799 | 0.93% | Shares |
| TD Asset Management Inc | $87,328,187 | 1,115,730 | 0.87% | Shares |
| Epoch Investment Partners, Inc. | $85,982,100 | 1,098,532 | 0.86% | Shares |
| NORTHERN TRUST CORP | $85,127,470 | 1,087,613 | 0.85% | Shares |
| Boston Trust Walden Corp | $84,771,263 | 1,083,062 | 0.85% | Shares |
| Caisse de depot et placement du Quebec | $83,939,801 | 1,072,439 | 0.84% | Shares |
| JANUS HENDERSON GROUP PLC | $79,741,989 | 1,233,658 | 0.80% | Shares |
| Assenagon Asset Management S.A. | $78,085,518 | 997,643 | 0.78% | Shares |
| FEDERATED HERMES, INC. | $75,298,949 | 962,041 | 0.75% | Shares |
| BANK OF MONTREAL /CAN/ | $73,764,153 | 942,432 | 0.74% | Shares |
| Mizuho Markets Cayman LP | $65,316,315 | 834,500 | 0.65% | Shares |
| Bank of New York Mellon Corp | $62,791,708 | 802,245 | 0.63% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $61,485,452 | 785,556 | 0.61% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $59,930,713 | 765,692 | 0.60% | Shares |
| Gotham Asset Management, LLC | $57,862,898 | 739,273 | 0.58% | Shares |
| JANE STREET GROUP, LLC | $54,372,917 | 694,684 | 0.54% | Shares |
| SEI INVESTMENTS CO | $43,135,607 | 551,116 | 0.43% | Shares |
| ROYAL BANK OF CANADA | $42,716,000 | 545,761 | 0.43% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $42,656,680 | 544,994 | 0.43% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $41,396,142 | 528,889 | 0.41% | Shares |
| Nuveen, LLC | $41,238,506 | 526,875 | 0.41% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RANDAL J. KIRK ×14 filings | Nov. 5, 2019 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 6, 2004 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 48 insiders · 27 officers · 19 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Helen Torley | PRESIDENT AND CEO | Sept. 11, 2026 M | 767,780 | 0 | 84 | $-39,847,684 |
| Gregory Ian Frost | CEO, President | Dec. 11, 2013 M | 3,641,380 | 0 | 0 | $0 |
| Jonathan E Lim | Chief Executive Officer | Feb. 4, 2010 A | 710,000 | 0 | 0 | $0 |
| Darren Snellgrove | SVP, Chief Financial Officer | July 1, 2026 A | · | 0 | 0 | $0 |
| Nicole Labrosse | SVP, CHIEF FINANCIAL OFFICER | Feb. 23, 2026 M | 38,494 | 0 | 0 | $0 |
| Laurie Stelzer | SVP, Chief Financial Officer | Feb. 22, 2020 M | 116,167 | 0 | 0 | $0 |
| Kurt A Gustafson | Vice President and CFO | Feb. 4, 2013 A | 35,667 | 0 | 0 | $0 |
| Cortney Caudill | SVP, CHIEF OPERATING OFFICER | March 10, 2026 M | 7,055 | 0 | 4 | $-2,233,042 |
| Mark J Gergen | SVP, Chief Operating Officer | Feb. 22, 2017 A | · | 0 | 0 | $0 |
| David A Ramsay | EVP, PRESIDENT, DRUG DELIVERY | July 1, 2026 A | 4,592 | 0 | 0 | $0 |
| Mark Howard Snyder | SVP, CHIEF LEGAL OFFICER | June 12, 2026 M | 49,929 | 0 | 0 | $0 |
| Michael J. Labarre | SVP, CHIEF TECHNICAL OFFICER | Feb. 27, 2025 S | 173,756 | 0 | 0 | $0 |
| Masaru Matsuda | SVP, General Counsel | Sept. 4, 2021 M | 20,049 | 0 | 0 | $0 |
| Benjamin Hickey | SVP, Chief Commerical Officer | Oct. 1, 2019 M | 13,226 | 0 | 0 | $0 |
| Dimitrios Chondros | SVP, Chief Medical Officer | Aug. 3, 2019 S | 38,584 | 0 | 0 | $0 |
| Alison A. Armour | SVP, Research & Development | June 3, 2019 A | · | 0 | 0 | $0 |
| Harry J Leonhardt | SVP, GC | April 13, 2019 M | 66,373 | 0 | 0 | $0 |
| Athena Countouriotis | SVP and Chief Medical Officer | Feb. 22, 2017 A | 39,077 | 0 | 0 | $0 |
| James P Shaffer | VP & Chief Commercial Officer | Feb. 6, 2014 A | 54,025 | 0 | 0 | $0 |
| Jean I Liu | VP & General Counsel | Feb. 6, 2014 A | 20,869 | 0 | 0 | $0 |
| Michael H. Shepard | VP, Chief Scientific Officer | Aug. 19, 2013 S | 13,198 | 0 | 0 | $0 |
| William J Fallon | VP, Manufacturing & Operations | May 10, 2011 A | · | 0 | 0 | $0 |
| Robert J Little | VP, Chief Commercial Officer | Feb. 4, 2010 A | 13,000 | 0 | 0 | $0 |
| Jonathan A Leff | VP, Chief Medical Officer | Aug. 6, 2009 A | · | 0 | 0 | $0 |
| Richard C Yocum | VP-Clinical Development | Feb. 6, 2008 A | 65,975 | 0 | 0 | $0 |
| Don A Kennard | Vice President, Regulatory Aff | Feb. 5, 2007 A | 3,000 | 0 | 0 | $0 |
| Carolyn Rynard | Vice President | Feb. 9, 2005 M | 100,000 | 0 | 0 | $0 |
| James M Daly | Director | Oct. 1, 2026 A | 1,169 | 0 | 0 | $0 |
| Matthew L. Posard | Director | Oct. 1, 2026 S | 53,609 | 0 | 8 | $-2,614,227 |
| Dannielle Appelhans | Director | Sept. 1, 2026 A | 1,161 | 0 | 0 | $0 |
| Bernadette Connaughton | Director | Aug. 10, 2026 S | 40,418 | 0 | 8 | $-839,371 |
| Mahesh Krishnan | Director | June 29, 2026 M | 14,462 | 0 | 1 | $-547,800 |
| James Paul Lang | Director | May 5, 2026 A | 4,685 | 0 | 0 | $0 |
| Barbara Gayle Duncan | Director | May 5, 2026 A | 23,715 | 0 | 0 | $0 |
| Jeffrey William Henderson | Director | May 5, 2026 A | 36,572 | 0 | 0 | $0 |
| Akiko Moni Miyashita | Director | May 1, 2025 A | 24,937 | 0 | 0 | $0 |
| Connie Matsui | Director | Nov. 29, 2024 G | 183,035 | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Director | May 5, 2023 A | 66,815 | 0 | 0 | $0 |
| Kenneth J Kelley | Director | April 14, 2021 S | 179,833 | 0 | 0 | $0 |
| Kathryn E Falberg | Director | May 4, 2016 A | 358,253 | 0 | 0 | $0 |
| John Stuart Patton | Director | Aug. 19, 2014 M | 179,876 | 0 | 0 | $0 |
| Robert L Engler MD | Director | Aug. 14, 2014 M | 273,176 | 0 | 0 | $0 |
| Steven T Thornton | Director | May 8, 2008 A | 30,000 | 0 | 0 | $0 |
| RANDAL J. KIRK | 10% owner | Aug. 28, 2018 S | 1,897,610 | 0 | 0 | $0 |
| Elaine D Sun | · | April 1, 2021 M | 14,018 | 0 | 0 | $0 |
| Matthew Hooper | · | Nov. 12, 2007 A | · | 0 | 0 | $0 |
| Mitch Keeler | · | March 10, 2004 J | 15,000 | 0 | 0 | $0 |
| Mellissa Day | · | March 10, 2004 J | 999 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 85 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2.94% | 136,508 SH | Oct. 2, 2026 | Daily |
| CSMD · Professionally Managed Portfolios | 2.87% | 157,971 NS | July 31, 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2.77% | 107,340 SH | Oct. 2, 2026 | Daily |
| RFG · Invesco Exchange-Traded Fund Trust | 2.67% | 83,551 SH | Oct. 2, 2026 | Daily |
| AZTD · Tidal Trust I | 2.45% | 11,232 NS | July 31, 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2.18% | 58,695 SH | Oct. 2, 2026 | Daily |
| JMID · Janus Detroit Street Trust | 1.93% | 5,526 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.78% | 226,384 NS | July 31, 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1.64% | 19,528 NS | July 31, 2026 | N-PORT |
| RNIN · EA Series Trust | 1.31% | 28,944 NS | July 31, 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1.25% | 19,931 NS | July 31, 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.20% | 586 NS | July 31, 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1.18% | 150,450 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.93% | 897,190 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.81% | 8,022 SH | Oct. 2, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.80% | 47,863 NS | July 31, 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.77% | 1,431 NS | July 31, 2026 | N-PORT |
| COWG · Pacer Funds Trust | 0.72% | 191,956 NS | July 31, 2026 | N-PORT |
| SAWS · ETF Series Solutions | 0.69% | 652 NS | July 31, 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.67% | 46,907 NS | July 31, 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0.59% | 81,331 SH | Oct. 2, 2026 | Daily |
| SMDX · Tidal Trust III | 0.58% | 9,164 NS | July 31, 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.49% | 117,038 SH | Aug. 19, 2026 | Daily |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.42% | 23,518 NS | July 31, 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.41% | 15,662 SH | Oct. 2, 2026 | Daily |
| IQSM · New York Life Investments ETF Trust | 0.37% | 14,792 NS | July 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.37% | 661,295 SH | Sept. 11, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.32% | 52,640 NS | July 31, 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.30% | 16,701 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.29% | 72,153 SH | Oct. 2, 2026 | Daily |
| PTMC · Pacer Funds Trust | 0.28% | 13,123 NS | July 31, 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.25% | 1,570,798 SH | Aug. 19, 2026 | Daily |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.25% | 191,789 SH | Aug. 19, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.25% | 19,561 NS | July 31, 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.24% | 18,498 NS | July 31, 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.22% | 654 NS | July 31, 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.21% | 52,033 NS | July 31, 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.21% | 1,742 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.21% | 62,464 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.20% | 68,924 SH | Sept. 11, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.20% | 14,085 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.19% | 49,681 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.18% | 325,861 NS | July 31, 2026 | N-PORT |
| SMMD · iShares Trust | 0.17% | 62,662 SH | Sept. 11, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.15% | 38,778 SH | Aug. 19, 2026 | Daily |
| LRGF · iShares Trust | 0.15% | 50,426 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.14% | 56,494 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.14% | 356,192 SH | Aug. 19, 2026 | Daily |
| FTLS · First Trust Exchange-Traded Fund III | 0.13% | 40,141 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.12% | 7,228 SH | Sept. 11, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.11% | 2,720,382 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.10% | 1,361,013 SH | Aug. 19, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 7,065 SH | Oct. 2, 2026 | Daily |
| IWR · iShares Trust | 0.09% | 482,899 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.09% | 23,542 NS | July 31, 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.07% | 8,107 SH | Oct. 2, 2026 | Daily |
| LRND · New York Life Investments ETF Trust | 0.06% | 2,678 NS | July 31, 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.04% | 163,642 SH | Sept. 11, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.04% | 18,538 SH | Oct. 2, 2026 | Daily |
| IWF · iShares Trust | 0.04% | 441,291 SH | Sept. 11, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.04% | 9,947 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.04% | 2,362 NS | July 31, 2026 | N-PORT |
| IUSG · iShares Trust | 0.03% | 103,928 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.03% | 192,370 NS | July 31, 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 185,857 SH | Aug. 19, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.02% | 9,295 NS | July 31, 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.02% | 26,549 SH | Aug. 19, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.02% | 29,890 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.02% | 5,290 SH | Sept. 9, 2026 | Daily |
| IWV · iShares Trust | 0.02% | 33,987 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.02% | 80,773 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.02% | 43,556 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.02% | 152,341 SH | Sept. 11, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.01% | 10,186 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3,763,482 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 96,181 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 19,437 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,862 SH | Aug. 19, 2026 | Daily |
| IJH · iShares Trust | · | 4,161,889 SH | Sept. 11, 2026 | Daily |
| IJK · iShares Trust | · | 686,856 SH | Sept. 11, 2026 | Daily |
| XJH · iShares Trust | · | 16,204 SH | Sept. 8, 2026 | Daily |
| ISCB · iShares Trust | · | 5,326 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 26,290 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 163,040 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 9,649 SH | Sept. 1, 2026 | Daily |
HALO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
9 analysts · 2026-10-02Mean target $99.56 -9.4%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | · |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | · |
| SMMT | $13.56B | -12.1 | · | · | -235.1% | · |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | · |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | · |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | · |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | · |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | · |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.